Trifluoroacetic acid → HCID 59472012, compound

HRID 2204883Notes

Reaction equation

HRID 2204883 reaction equation
C(O)(C(F)(F)F)=O.[NH2:8][C:9]1[C:10]([C:27]2[O:31][C:30]([CH2:32][C:33]([O:35]C(C)(C)C)=[O:34])=[N:29][N:28]=2)=[N:11][C:12]([C:15]2[CH:20]=[CH:19][C:18]([S:21]([CH:24]([CH3:26])[CH3:25])(=[O:23])=[O:22])=[CH:17][CH:16]=2)=[CH:13][N:14]=1>C(Cl)Cl>[NH2:8][C:9]1[C:10]([C:27]2[O:31][C:30]([CH2:32][C:33]([OH:35])=[O:34])=[N:29][N:28]=2)=[N:11][C:12]([C:15]2[CH:20]=[CH:19][C:18]([S:21]([CH:24]([CH3:26])[CH3:25])(=[O:23])=[O:22])=[CH:17][CH:16]=2)=[CH:13][N:14]=1

Participants

4

Procedure

TFA (500 μL, 6.490 mmol) was added to a stirred solution of tert-butyl 2-(5-(3-amino-6-(4-(isopropylsulfonyl)phenyl)pyrazin-2-yl)-1,3,4-oxadiazol-2-yl)acetate (45 mg, 0.083 mmol) in CH2Cl2 (5 mL) and the reaction stirred at ambient temperature for 18 h. The solvent was removed in vacuo and the residue azeotroped with CH2Cl2 (2×5 mL) and ether (2×5 mL). The material was purified by reverse phase preparative HPLC [Waters Sunfire C18, 10 μM, 100 Å column, gradient 10%-95% B (solvent A: 0.05% TFA in water; solvent B: CH3CN) over 16 minutes at 25 mL/min]. The fractions were collected and freeze-dried to give the title compound as a yellow solid (16.7 mg, 49%); 1H NMR (400 MHz, DMSO) d 1.19 (d, 6H), 3.45 (m, 1H), 4.27 (s, 2H), 7.85 (br s, 2H), 7.96 (d, 2H), 8.30 (d, 2H), 9.04 (s, 1H) and 13.30 (s, 1H) ppm; MS (ES+) 404.2

Workup

  1. customThe solvent was removed in vacuo
  2. customthe residue azeotroped with CH2Cl2 (2×5 mL) and ether (2×5 mL)
  3. customThe material was purified by reverse phase preparative HPLC [Waters Sunfire C18, 10 μM, 100 Å column, gradient 10%-95% B (solvent A: 0.05% TFA in water; solvent B: CH3CN) over 16 minutes at 25 mL/min]
  4. customThe fractions were collected
  5. customfreeze-dried

Sources & evidence

ORD record
ord-62ad2bb387184f9482b61892400eaa82
Source dataset
uspto-grants-2016_06
Patent number
US09365557B2

Reaction notes

Loading…